FATE THERAPEUTICS INC Quarterly Operating Margin in % from Q4 2017 to Q2 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Fate Therapeutics Inc quarterly/annual Operating Margin history and growth rate from Q4 2017 to Q2 2024.
  • Fate Therapeutics Inc Operating Margin for the quarter ending June 30, 2024 was -1.59K %, a 682% decline year-over-year.
  • Fate Therapeutics Inc annual Operating Margin for 2023 was -300 %, a 6.36% increase from 2022.
  • Fate Therapeutics Inc annual Operating Margin for 2022 was -320 %, a 17.6% increase from 2021.
  • Fate Therapeutics Inc annual Operating Margin for 2021 was -389 %, a 4.64% increase from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -1.59K -1.38K -682% Apr 1, 2024 Jun 30, 2024
Q1 2024 -3.29K -3.1K -1614% Jan 1, 2024 Mar 31, 2024
Q4 2023 -300 +20.4 +6.36% Oct 1, 2023 Dec 31, 2023
Q3 2023 -195 +259 +57.1% Jul 1, 2023 Sep 30, 2023
Q2 2023 -203 +210 +50.8% Apr 1, 2023 Jun 30, 2023
Q1 2023 -192 +197 +50.6% Jan 1, 2023 Mar 31, 2023
Q4 2022 -320 +68.3 +17.6% Oct 1, 2022 Dec 31, 2022
Q3 2022 -454 -123 -37.2% Jul 1, 2022 Sep 30, 2022
Q2 2022 -413 -83.7 -25.4% Apr 1, 2022 Jun 30, 2022
Q1 2022 -389 -39.6 -11.3% Jan 1, 2022 Mar 31, 2022
Q4 2021 -389 +18.9 +4.64% Oct 1, 2021 Dec 31, 2021
Q3 2021 -331 +344 +50.9% Jul 1, 2021 Sep 30, 2021
Q2 2021 -329 +575 +63.6% Apr 1, 2021 Jun 30, 2021
Q1 2021 -349 +738 +67.9% Jan 1, 2021 Mar 31, 2021
Q4 2020 -407 +536 +56.8% Oct 1, 2020 Dec 31, 2020
Q3 2020 -675 +252 +27.2% Jul 1, 2020 Sep 30, 2020
Q2 2020 -904 +54.5 +5.69% Apr 1, 2020 Jun 30, 2020
Q1 2020 -1.09K +71.4 +6.17% Jan 1, 2020 Mar 31, 2020
Q4 2019 -943 +472 +33.4% Oct 1, 2019 Dec 31, 2019
Q3 2019 -927 +598 +39.2% Jul 1, 2019 Sep 30, 2019
Q2 2019 -958 +412 +30% Apr 1, 2019 Jun 30, 2019
Q1 2019 -1.16K -32.3 -2.87% Jan 1, 2019 Mar 31, 2019
Q4 2018 -1.42K -390 -38% Oct 1, 2018 Dec 31, 2018
Q3 2018 -1.52K Jul 1, 2018 Sep 30, 2018
Q2 2018 -1.37K Apr 1, 2018 Jun 30, 2018
Q1 2018 -1.13K Jan 1, 2018 Mar 31, 2018
Q4 2017 -1.03K Oct 1, 2017 Dec 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.